Clearmind Medicine (FRA:CWY0) Change In Payables And Accrued Expense : €-0.23 Mil (TTM As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Change In Payables And Accrued Expense?

Clearmind Medicine's Change In Payables And Accrued Expense for the quarter that ended in Jan. 2024 was €-0.20 Mil. It means Clearmind Medicine's Accounts Payable & Accrued Expense declined by €0.20 Mil from Oct. 2023 to Jan. 2024 .

Clearmind Medicine's Change In Payables And Accrued Expense for the fiscal year that ended in Oct. 2023 was €-0.54 Mil. It means Clearmind Medicine's Accounts Payable & Accrued Expense declined by €0.54 Mil from Oct. 2022 to Oct. 2023 .

Clearmind Medicine Change In Payables And Accrued Expense Historical Data

The historical data trend for Clearmind Medicine's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Change In Payables And Accrued Expense Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.03

-0.02

0.18

0.83

-0.54

Clearmind Medicine Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-0.50	0.11	-0.35	0.22	-0.20

Clearmind Medicine Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.23 Mil.

Clearmind Medicine Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (FRA:CWY0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (FRA:CWY0) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

CMND:USA CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.

Clearmind Medicine (FRA:CWY0) Headlines

No Headlines